Classe, J.-M.; Asselain, B.; Campion, L.; Berton, D.; Frenel, J.-S.; Lécuru, F.; Ferron, G.; Gladieff, L.; Bourgin, C.; Loaec, C.
Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review. Cancers 2022, 14, 172.
https://doi.org/10.3390/cancers14010172
AMA Style
Classe J-M, Asselain B, Campion L, Berton D, Frenel J-S, Lécuru F, Ferron G, Gladieff L, Bourgin C, Loaec C.
Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review. Cancers. 2022; 14(1):172.
https://doi.org/10.3390/cancers14010172
Chicago/Turabian Style
Classe, Jean-Marc, Bernard Asselain, Loic Campion, Dominique Berton, Jean-Sébastien Frenel, Fabrice Lécuru, Gwenael Ferron, Laurence Gladieff, Charlotte Bourgin, and Cecile Loaec.
2022. "Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review" Cancers 14, no. 1: 172.
https://doi.org/10.3390/cancers14010172
APA Style
Classe, J.-M., Asselain, B., Campion, L., Berton, D., Frenel, J.-S., Lécuru, F., Ferron, G., Gladieff, L., Bourgin, C., & Loaec, C.
(2022). Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review. Cancers, 14(1), 172.
https://doi.org/10.3390/cancers14010172
